Clinical trial / 2016
Tart cherry concentrate lowered systolic blood pressure without improving cognitive performance
In a randomized crossover trial of 27 middle-aged volunteers, participants ingested a 60 ml dose of Montmorency tart cherry concentrate or placebo. Tart cherry intake significantly decreased systolic blood pressure over 3 hours, with peak reductions of 6±2 mmHg at 1 hour compared to placebo. It also altered total and oxygenated hemoglobin levels during cognitive tasks at 1 hour, but cognitive function and mood were not altered.
- Study type
- Randomized crossover trial
- Who was studied
- 27 middle-aged adults aged 45-60 years
- What was measured
- Blood pressure, cerebrovascular responses, and cognitive performance
THE PAPER
Montmorency Tart cherries (Prunus cerasus L.) modulate vascular function acutely, in the absence of improvement in cognitive performance.
Keane KM, Haskell-Ramsay CF, Veasey RC, Howatson G. Br J Nutr, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.